(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Directa Plus PLC - London-based producer and supplier of graphene products for use in industrial markets - In 2023, pretax loss narrows to EUR4.3 million from EUR5.3 million. Revenue fell 3.0% to EUR10.5 million from EUR10.9 million. Other expenses declined 16% to EUR3.7 million from EUR4.4 million. Chief Executive Officer Giulio Cesareo says: "[The company benefitted] from improved margins driven by the growing value of our technology, successful investment in innovation, and a reduction in direct costs. We also secured our largest contract to date".

----------

Lexington Gold Ltd - South Africa and US-focused gold exploration and development company - In 2023, pretax loss narrows to USD61,000 from USD924,000. No revenue generated. Operating expenses rose 8.8% to USD770,000 from USD708,000. Cash and cash equivalents held multiplied to USD2.6 million from USD424,000. Total assets increase to USD18.2 million from USD5.1 million. Post-period end, further development progress made across operations, with testing highlighting the potential of various projects.

----------

Great Southern Copper PLC - Chile-focused copper, gold, and lithium explorer - GBP1.3 million raised through a placing and subscription of 104.4 million shares at price of GBP0.012 each. Proceeds will be used to fund exploration and drilling work at the Especularita project, as well as for general working capital and administrative costs.

----------

Costain Group PLC - Maidenhead, England-based infrastructure solutions company - Wins contract for GBP65 million water supply resilience and infrastructure upgrade programme along with joint venture partner MWH Treatment Ltd. Contract awarded by Southern Water Services Ltd and will run until late 2025.

----------

EDX Medical Group PLC - Cambridge, England-based developer of digital diagnostics products and medical services - Signs exclusive distribution agreement to market the cResponse cancer assay in UK, Sweden, Finland, Norway, and Denmark for Curesponse Ltd.

----------

Plant Health Care PLC - North Carolina, US-based provider of propriety biological products for agriculture - Agrees to terms of an acquisition by PI Industries Ltd. PHC shareholders to receive 9.0 pence in cash per share held. Acquisition valued at GBP32.8 million, a 57% premium from closing price of 5.7p on June 25.

----------

Zephyr Energy PLC - Rocky Mountain region-focused oil & gas company - 36-2R well production test have commenced with the well in its clean-up phase. Operations are proceeding at a conservative pace and the period of clean-up is longer than originally forecast. Production test is expected to commence shortly after clean-up and related operations have been completed. Company further announced a successful redetermination process by lender First International Bank & Trust, reaffirming an existing USD15.2 million credit facility. Additional USD5.6 million loan secured with interest rate of 10% per annum. Proceeds from new loan, along with USD400,000 cash, to repay remaining USD6 million of bridge loan. Following this, total borrowings at USD29.4 million.

----------

Aterian PLC - London-based critical metal exploration and development company - Receives notices to convert remaining GBP500,000 of outstanding convertible loan notes issued on May 3. Additionally, following requests from three suppliers seeking an increased shareholding in Aterian, the company has agreed to convert GBP42,197 of creditor balances. The company will therefore convert an aggregate of GBP542,197 at 70 pence per share in exchange for the issue of 774,566 new ordinary shares of 10p each.

----------

By Elijah Dale, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.